NNIT is pleased to announce its role as a strategic implementation partner for Eirgen Pharma’s new Electronic Batch Record (EBR) system, internally referred to as Project Elevate. This initiative is a cornerstone of Eirgen’s digital transformation strategy and marks a decisive shift away from manual, paper-based batch documentation toward a fully digitized, real-time operational environment. The s
The overall financial performance in Q1 2025 shows flat growth due to a challenging start to the year.
NNIT’s Q1 2025 financial performance was expected to be moderate, but the increased macroeconomic and geopolitical uncertainty has impacted the company to a larger extent than expected. First quarter showed a flat growth and based on the realized results and the continued uncertainty, NNIT ad
We are proud to share that NNIT has received Veeva partner acknowledgement for Veeva Post-Implementation for the following Vault applications: Vault QualityDocs, Vault Submissions, Vault eTMF, Vault QMS, and Vault CTMS.
The Group continued to grow revenue organically and deliver profit margin in line with the updated outlook for the year.
NNIT continues its commitment to focus on bringing digital transformation solutions to life sciences internationally. Regional execution of this strategy remains key, and Pia Bundgaard Ingels is now heading up NNIT’s activities in Europe.
A Challenging Third Quarter. Necessary Actions Taken to Improve Performance in 2024 and Long-term
We are delighted to announce that NNIT is a Veeva AI Partner, joining a group of select global partners.
NNIT relocated to a new office space in Krakow, Poland, on September 1, and a grand opening was held on September 12.
Solid organic growth of 11%, profitability continued to improve, and important strategic milestones reached.
The integration of NNIT Group Company SL Controls was initiated in May, and plans are in place for completion by year-end 2024.
On June 1, NNIT in Czech Republic relocated to the Na Knizeci Office situated on the left bank of the Vltava River in Smíchov City, Prague.
After more than 14 years at the same location in Switzerland, NNIT has relocated to Grosspeter Tower, an impressive 21-storey structure in the city of Basel.
The life sciences market in Europe is idling – even hesitant – following the macro-economic and geo-political hits of war, energy crisis, inflation, increasing interest rates and increasing EU regulation. But Ricco Larsen, Senior Vice President of Life Sciences Europe at NNIT, remains positive based on a firm belief in the resilience of the industry.
Revenue growth of 12.2%, an operating profit margin of 5.2% – and full-year financial outlook maintained.
NNIT’s Migration Powerhouse, renowned for its expertise in critical data migrations where compliance and accuracy are paramount, is proud to announce the launch of the latest iteration of its flagship software, Valiance TRUseries 5.0.
A new global structure dedicated to AI and led by Director Sam Laermans has been created to ensure unity, best practice, and maximum utilization of expertise and resources across our four regional AI business units.
Our China head office has relocated from Tianjin Jinwan Mansion to Tianjin Luneng International Center to provide employees with a more convenient and flexible office environment as well as better surroundings for the collaboration with our customers and partners.
More than 400 talented and ambitious young people were nominated for this year's Talent 100 published by Berlingske. Only 100 talents were ultimately selected for this year’s list, and Marina Prodan is one of them.
NNIT completes successful collaboration with a Top 20 Biopharma pioneer in transitioning to a new Electronic Data Capture (EDC) platform for their clinical trials.
Nearly half of the respondents in NNIT’s Expectation Barometer 2023 survey place heightened integration of AI at the top of their priority list. However, prior to fully embracing AI, life sciences companies should prioritize the people and business processes that will become AI’s closest allies.
